from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2421c/nadD

LFCtreatmentdescriptionclass of inhibitor

-0.009

Amikacinug/mL Amikacintranslation

1.799

Cap5-10ug/mL Capreomycintranslation

3.019

Rox10-50 ug/mL Roxithromycintranslation

0.247

SM2-5 ug/mL Streptomycintranslation

0.812

Tet5-10 ug/mL Tetracyclinetranslation

-0.926

Rif0.2-5ug/mL Rifampicintranscription

-0.295

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.326

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-2.169

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.115

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.119

Clofazimine10-13 ug/mL Clofaziminerespiration

0.186

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-1.630

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-2.973

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-1.267

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.012

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.218

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.347

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-1.309

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.213

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-2.382

KCN5-20 ug/mL Potassium cyaniderespiration

-0.995

NaN30.2-2 mM Sodium aziderespiration

0.239

Nigericin50 uM Nigericinrespiration

-0.161

TRC10-150 ug/mL Triclosanrespiration

-0.759

TRZ10-25 ug/mL Thioridazinerespiration

0.092

Valinomycin0.5-10 uM Valinomycinrespiration

0.893

ZnSO42 mM ZnSO4respiration

-0.076

menadione6-10 ug/mL Menadionerespiration

0.335

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.259

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.179

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.212

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.564

NRP_1Non-replicating persistence stage 1dosRassociated

0.525

Amp0.2mg/mL AmpicillincellWall

0.203

Cephalexin20-100 ug/mL CephalexincellWall

0.979

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.014

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.192

EMB10-20 ug/mL EthambutolcellWall

0.786

Eta12-40 ug/mL EthionamidecellWall

0.813

INH0.2-0.4 ug/mL IsoniazidcellWall

0.571

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.226

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.504

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.565

BZA0.12 mg/mL BenzamidearomaticAmides

-0.504

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.318

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.516

H2O24 mM hydrogen peroxideDNAdamaging

0.682

Levo10 ug/mL LevofloxacinDNAdamaging

0.375

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-1.339

Novobiocin10 ug/mL NovobiocinDNAdamaging

1.040

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.406

UVUV-irradiationDNAdamaging

-0.683

ARP41-4 ug/mL Antitubercular compound ARP4?

0.251

Antimycin12.5-50 ug/mL Antimycin A?

0.399

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.364

PA_110-50 ug/mL Antitubercular compound PA-1?

0.576

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.648

PA8240.2-2 ug/mL PA-824?

-0.583

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.135

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.288

Verapamil50 uM Verapamil?

-0.410

mercaptoethanol2 mM 2-Mercaptoethanol?

0.666

methoxatin10-20 ug/mL Methoxatin?